Spanish study gives reassurance: small HIV blips do not predict treatment failure
Most people taking second-line ART in sub-Saharan Africa achieve viral suppression but there's a need for third-line treatment options
Very high levels of drug resistance seen in people experiencing first-line antiretroviral therapy failure in Kenya
HIV rapidly develops resistance to gene-editing cure technology
Resistance to anti-HIV drugs in steep decline in Switzerland
Combination inhibitor BMS-986197 demonstrates good activity against HIV in early study
Almost-certain case of PrEP failure due to drug resistance reported at CROI 2016
